FDA Reopens Review of Moderna’s mRNA Flu Shot
The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine…
mRNA cancer treatment 2025
Read More
FDA Rejects Moderna Application Over Clinical Trial Standards for mRNA Flu Vaccine
The Food and Drug Administration has declined to review an application from Moderna for its experimental mRNA influenza vaccine, citing…
Russia’s mRNA Cancer Vaccine Set for 2025 Launch: A Major Leap in Personalized Cancer Treatment
Russia is preparing to introduce its first mRNA-based cancer vaccine in early 2025, a development that could mark a major…